IL96134A0 - Substituted cycloalkano(b)-dihydroindole-and-indolesulphonamides,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted cycloalkano(b)-dihydroindole-and-indolesulphonamides,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL96134A0
IL96134A0 IL96134A IL9613490A IL96134A0 IL 96134 A0 IL96134 A0 IL 96134A0 IL 96134 A IL96134 A IL 96134A IL 9613490 A IL9613490 A IL 9613490A IL 96134 A0 IL96134 A0 IL 96134A0
Authority
IL
Israel
Prior art keywords
dihydroindole
indolesulphonamides
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL96134A
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL96134A0 publication Critical patent/IL96134A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Substituted antithrombotic substituted cycloalkano[b]dihydroindole- and -indole-sulphonamides for treatment of thromboses, thromboembolisms, ischaemias, asthma and allergies, of the formula <IMAGE>other radicals, X is aryl, alkyl or CF3, m and Z each is 1,2,3 or 4, n is 0,1 or 2, A is a bond or -NH-, and Y is OH, alkoxy, aryloxy, amino or sulphonylamine, with the proviso, that in all cases, two of the substituents R1-R4 are other than hydrogen in the event that m represents the number 2 and Y represents the hydroxyl group, or a salt thereof.
IL96134A 1989-10-30 1990-10-26 Substituted cycloalkano(b)-dihydroindole-and-indolesulphonamides,their preparation and pharmaceutical compositions containing them IL96134A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898924392A GB8924392D0 (en) 1989-10-30 1989-10-30 Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides

Publications (1)

Publication Number Publication Date
IL96134A0 true IL96134A0 (en) 1991-07-18

Family

ID=10665396

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96134A IL96134A0 (en) 1989-10-30 1990-10-26 Substituted cycloalkano(b)-dihydroindole-and-indolesulphonamides,their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (3) US5039670A (en)
EP (1) EP0425906B1 (en)
JP (1) JPH03151360A (en)
KR (1) KR910007876A (en)
CN (1) CN1051354A (en)
AT (1) ATE102185T1 (en)
AU (1) AU628665B2 (en)
CA (1) CA2028621A1 (en)
DE (1) DE59004764D1 (en)
DK (1) DK0425906T3 (en)
ES (1) ES2062250T3 (en)
FI (1) FI905294A0 (en)
GB (1) GB8924392D0 (en)
HU (1) HUT57190A (en)
IE (1) IE903869A1 (en)
IL (1) IL96134A0 (en)
NO (1) NO904487L (en)
NZ (1) NZ235860A (en)
PH (1) PH27484A (en)
PT (1) PT95728A (en)
ZA (1) ZA908637B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0528762T3 (en) * 1991-08-15 1997-08-25 Ciba Geigy Ag N-acyl-N-heterocyclyl or naphthylalkyl amino acids as angiotensin II antagonists
DE19506739A1 (en) * 1995-02-27 1996-08-29 Bayer Ag [3-Amino] tetrahydrocarbazole propanoic acid ester
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
AU2003231509A1 (en) * 2002-05-16 2003-12-02 Shionogi And Co., Ltd. Compound exhibiting pgd 2 receptor antagonism
AU2003231513A1 (en) * 2002-05-16 2003-12-02 Shionogi And Co., Ltd. Pgd2 receptor antagonist
AU2004247676A1 (en) * 2003-06-10 2004-12-23 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
CN101203491A (en) * 2005-06-24 2008-06-18 伊莱利利公司 Tetrahydrocarbazole derivatives used as androgen receptor modifier
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
UA98777C2 (en) * 2006-11-20 2012-06-25 Эли Лилли Энд Компани Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
CN101434571B (en) * 2007-11-13 2012-05-30 杭州容立医药科技有限公司 Cycloalkano [1,2-b] indole sulfonic acid amide, and method for synthesizing isomer or salt thereof
CN102026974B (en) * 2008-05-16 2013-08-28 伊莱利利公司 Tetrahydrocyclopenta[b]indole androgen receptor modulators
MY179356A (en) 2014-03-17 2020-11-05 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators
MX2018003202A (en) 2015-09-15 2018-06-08 Idorsia Pharmaceuticals Ltd Crystalline forms.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3514696A1 (en) * 1985-04-24 1986-11-06 Bayer Ag, 5090 Leverkusen N-INDOLYLETHYL SULPHONIC ACID AMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE3525801A1 (en) * 1985-07-19 1987-01-22 Hoechst Ag TERTIA HYDROXYALKYLXANTHINE, METHOD FOR THE PRODUCTION THEREOF, THE MEDICINAL PRODUCT CONTAINING IT AND THEIR USE
US4808608A (en) * 1986-01-23 1989-02-28 Merck & Co., Inc. Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
DE3768097D1 (en) * 1986-01-23 1991-04-04 Merck Frosst Canada Inc TETRAHYDROCARBAZOL-1-ALKANIC ACIDS.
DE3631824A1 (en) * 1986-02-21 1988-03-31 Bayer Ag CYCLOALKANO (1.2-B) INDOL-SULFONAMIDE
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
DE3613623A1 (en) * 1986-04-23 1987-10-29 Bayer Ag N-DIHYDROINDOLYLETHYL SULFONAMIDE

Also Published As

Publication number Publication date
DK0425906T3 (en) 1994-04-11
ES2062250T3 (en) 1994-12-16
AU6384890A (en) 1991-06-20
NO904487L (en) 1991-05-02
NZ235860A (en) 1992-09-25
EP0425906A3 (en) 1992-01-22
US5374647A (en) 1994-12-20
KR910007876A (en) 1991-05-30
HU906925D0 (en) 1991-05-28
JPH03151360A (en) 1991-06-27
NO904487D0 (en) 1990-10-17
CN1051354A (en) 1991-05-15
PT95728A (en) 1991-09-13
PH27484A (en) 1993-07-23
DE59004764D1 (en) 1994-04-07
HUT57190A (en) 1991-11-28
CA2028621A1 (en) 1991-05-01
US5039670A (en) 1991-08-13
IE903869A1 (en) 1991-05-08
FI905294A0 (en) 1990-10-26
ATE102185T1 (en) 1994-03-15
GB8924392D0 (en) 1989-12-20
EP0425906B1 (en) 1994-03-02
AU628665B2 (en) 1992-09-17
US5096897A (en) 1992-03-17
ZA908637B (en) 1991-08-28
EP0425906A2 (en) 1991-05-08

Similar Documents

Publication Publication Date Title
IL96134A0 (en) Substituted cycloalkano(b)-dihydroindole-and-indolesulphonamides,their preparation and pharmaceutical compositions containing them
MY109669A (en) N,o-sulphated heparosans, process for, preparing them and pharmaceutical compositions containing them
MX9604020A (en) Arylalkyldiazinones.
FR2645866B1 (en) NEW LIPOPOLYAMINES, THEIR PREPARATION AND THEIR USE
GEP20002210B (en) Acridine Derivatives
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
EP0163599A3 (en) Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents
CA2067184A1 (en) New linker for bioactive agents
HUT66370A (en) Polymers containing diester units and process for producing thereof
GB1525762A (en) Quaternary ammonium polymers
ATE36859T1 (en) 4&#39;-DEMETHYL-4-EPIPODOPHYLLOTOXIN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.
ES8604985A1 (en) Novel platinum complexes
CA2121997A1 (en) 3-deoxy oligosaccharides, processes for preparing them and pharmaceutical compositions containing them
MY114282A (en) Anthracycline derivatives
ES8407477A1 (en) Derivatives of N-iminopyridinium betaines, their preparation and their use as medicaments.
WO1992009574A3 (en) Poly-aminopyrrolecarboxamido derivatives, processes for their preparation and pharmaceutical compositions containing them
IL97158A0 (en) Side-chain homologous vitamin d derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
TW369531B (en) New taxoids, their preparation and pharmaceutical compositions containing them
ZA913644B (en) 3&#39;-deamino-4&#39;-deoxy-4&#39;-amino-8-fluoroanthracyclines and processes for their preparation
MY108826A (en) (alpha)-aryl-(alpha) hydroxy-(beta)-imidazolindyl-propionamides
EP0204172A3 (en) Phenylpyrazine derivatives, processes for preparing them, pharmaceutical composition and use
HUP9802072A2 (en) Benzothiopyranoindazole derivatives and pharmaceutical compositions containing them
TW334463B (en) 4-methyl-1-pentene polymer compositions the polymer compositions have high permeability to gas and have improved flexibility and mechanical properties
CA2218664A1 (en) New n-acylated 4-hydroxyphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them